Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation

For success in clinical trials, eliminating inclusion of patients with irreversible recovery is important. The purpose of this study was to identify the patient population who do not survive for more than 3 days. A total of 449 patients with sepsis suspected of having disseminated intravascular coag...

Descripción completa

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Arakawa, Makoto, Ohchi, Yoshifumi, Arai, Takao, Sato, Koichi, Wada, Hideo, Levy, Jerrold H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714842/
https://www.ncbi.nlm.nih.gov/pubmed/30198317
http://dx.doi.org/10.1177/1076029618797474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714842/
https://www.ncbi.nlm.nih.gov/pubmed/30198317
http://dx.doi.org/10.1177/1076029618797474

Ejemplares similares